Read: BioMed X starts new schizophrenia research program with Boehringer Ingelheim BioMed X starts new schizophrenia research program with Boehringer Ingelheim Jan 13, 2020
Read: BioMed X and Boehringer Ingelheim to investigate early intervention in psychiatric diseases BioMed X and Boehringer Ingelheim to investigate early intervention in psychiatric diseases Jan 17, 2019
Read: BioMed X and Boehringer Ingelheim start new joint research group in bacterial modulation of innate immunity BioMed X and Boehringer Ingelheim start new joint research group in bacterial modulation of innate immunity Nov 27, 2017
Read: BioMed X and Boehringer Ingelheim launch new crowdsourcing project to identify key regulatory mechanisms in innate immunity BioMed X and Boehringer Ingelheim launch new crowdsourcing project to identify key regulatory mechanisms in innate immunity Feb 6, 2017
Read: BioMed X and Merck start new project in cancer research BioMed X and Merck start new project in cancer research Nov 3, 2016
Read: BioMed X announces the start of new research team on Oral Biofilm Disruption through continued collaboration with Johnson & Johnson Innovation BioMed X announces the start of new research team on Oral Biofilm Disruption through continued collaboration with Johnson & Johnson Innovation Sep 6, 2016
Read: Boehringer Ingelheim and BioMed X start new project to explore and develop unprecedented new treatment approaches for psychiatric diseases applying crowdsourcing Boehringer Ingelheim and BioMed X start new project to explore and develop unprecedented new treatment approaches for psychiatric diseases applying crowdsourcing May 23, 2016
Read: Boehringer Ingelheim and BioMed X extend collaboration to discover novel therapeutic concepts for the treatment of psychiatric diseases Boehringer Ingelheim and BioMed X extend collaboration to discover novel therapeutic concepts for the treatment of psychiatric diseases Nov 2, 2015
Read: Boehringer Ingelheim and BioMed X collaborate to discover new epigenetic regulators of COPD Boehringer Ingelheim and BioMed X collaborate to discover new epigenetic regulators of COPD Jan 5, 2015
In the Media In the Media Media is constantly reporting on BioMed X Institute and its work. Read our current media coverage. Read more
Our Events Our Events Interested to learn more about our innovation model and our research projects? Check out our list of events. Read more
